Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NASDAQ: ZYME) | Delayed: 27.69 +0.78 (2.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.91 | 52 Week High | $ | |||
| Open | $26.96 | 52 Week Low | $ | |||
| Day High | $28.25 | P/E | N/A | |||
| Day Low | $26.90 | EPS | $ | |||
| Volume | 486,024 | |||||
